Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $3.15 Million - $4.71 Million
9,300 Added 244.42%
13,105 $4.99 Million
Q3 2023

Nov 14, 2023

SELL
$369.35 - $548.43 $121,885 - $180,981
-330 Reduced 7.98%
3,805 $1.87 Million
Q2 2023

Aug 14, 2023

SELL
$360.14 - $422.58 $143,695 - $168,609
-399 Reduced 8.8%
4,135 $1.61 Million
Q4 2022

Feb 14, 2023

SELL
$342.17 - $402.31 $7.94 Million - $9.34 Million
-23,216 Reduced 83.66%
4,534 $1.72 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $8 Million - $9.23 Million
23,322 Added 526.69%
27,750 $9.8 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $1.19 Million - $1.68 Million
4,428 New
4,428 $1.68 Million
Q3 2020

Nov 16, 2020

SELL
$215.51 - $272.51 $1.11 Million - $1.4 Million
-5,155 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$127.44 - $232.72 $454,451 - $829,879
-3,566 Reduced 40.89%
5,155 $1.16 Million
Q1 2020

May 14, 2020

SELL
$108.83 - $165.23 $190,234 - $288,822
-1,748 Reduced 16.7%
8,721 $1.15 Million
Q4 2019

Feb 14, 2020

SELL
$106.59 - $164.21 $74,186 - $114,290
-696 Reduced 6.23%
10,469 $1.68 Million
Q3 2019

Nov 14, 2019

BUY
$113.31 - $150.51 $99,599 - $132,298
879 Added 8.55%
11,165 $1.27 Million
Q2 2019

Aug 15, 2019

BUY
$115.0 - $141.58 $828,345 - $1.02 Million
7,203 Added 233.64%
10,286 $1.46 Million
Q1 2019

May 14, 2019

BUY
$98.85 - $134.59 $304,754 - $414,940
3,083 New
3,083 $385,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.